Zobrazeno 1 - 10
of 397
pro vyhledávání: '"M A, Popova"'
Autor:
M. О. Popova, V. V. Markelov
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 185-198 (2024)
In current immunotherapy, a promising direction is therapy using chimeric antigen receptor T cells (CAR-T). Among malignant hematological diseases, even at advanced stages and resistant/recurrent forms, the use of CAR-T demonstrates high efficiency.
Externí odkaz:
https://doaj.org/article/110e44ba698b4458976c40245bec939d
Autor:
M. M. Kaganova, I. P. Shilovskiy, E. D. Timotievich, K. V. Yumashev, D. A. Gurskii, K. V. Vinogradova, M. V. Popova, M. R. Khaitov
Publikováno v:
Медицинская иммунология, Vol 26, Iss 5, Pp 1107-1114 (2024)
Allergic rhinitis (AR) is an inflammatory disease of the upper respiratory tract (nasal mucosa). AR affects up to 40% of the world’s population; in the Russian Federation, the incidence is 18% to 30%, depending on the region. Despite the fact that
Externí odkaz:
https://doaj.org/article/5cf5cec5475f4820943040c215bfd52c
Autor:
N. G. Nilov, I. I. Ryff, S. P. Berezovskaya, V. Yu. Stamatidi, M. S. Popova, V. A. Volynkin, V. V. Llikhovskoi
Publikováno v:
Труды по прикладной ботанике, генетике и селекции, Vol 185, Iss 2, Pp 69-81 (2024)
Background. Salt stress reduces water supply and causes ionic imbalance in the plant, eventually leading to a decrease in plant growth, functional activity, and productivity. Variable salinity levels in the field make it difficult to select salt-tole
Externí odkaz:
https://doaj.org/article/aeb1fa96e22c4ace9f817604a37c7ac4
Autor:
I. P. Shilovskiy, G. B. Pasikhov, V. V. Smirnov, I. A. Kofiadi, M. V. Popova, P. A. Strueva, M. R. Khaitov
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 24, Iss 2, Pp 157-171 (2024)
INTRODUCTION. Small interfering RNAs (siRNAs) are among the most promising types of therapeutic nucleic acids aiming at the inhibition of pathogenetically relevant gene expression through the RNA interference mechanism. However, the limited bioavaila
Externí odkaz:
https://doaj.org/article/eb2d2fbfb84c4e88a2f8d5a7cea9133d
Autor:
E. S. Vetrova, P. K. Karnakova, N. S. Bagaeva, K. K. Karnakova, M. O. Popova, A. A. Popova, O. A. Archakova, T. N. Komarov, I. E. Shohin
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 2, Pp 233-244 (2024)
Introduction. The use of tofacitinib as a pharmacological treatment for rheumatoid arthritis remains relevant in the light of the predicted increase in prevalence of the disease. At the same time, due to the withdrawal of several foreign pharmaceutic
Externí odkaz:
https://doaj.org/article/08cb41cc1d3d4366bc75f91b87a0fb5e
Autor:
T. N. Komarov, K. K. Karnakova, N. S. Bagaeva, O. A. Archakova, M. O. Popova, V. S. Shcherbakova, K. Ya. Zaslavskaya, P. A. Bely, I. E. Shohin
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 1, Pp 272-280 (2024)
Introduction. COVID-19 (Coronavirus disease 2019) almost 4 years after he start of the pandemic is still a significant public health problem. SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) that causes COVID-19 continues to mutate and sp
Externí odkaz:
https://doaj.org/article/e107ec5b3e7946f48b26c0a04f267d34
Autor:
U. D. Filonova, P. K. Karnakova, K. K. Karnakova, M. O. Popova, A. A. Popova, O. A. Archakova, T. N. Komarov, I. E. Shohin
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 1, Pp 224-240 (2024)
Introduction. Apixaban is an anticoagulant used in a number of thromboembolic diseases with an improved benefit-to-risk ratio, according to multiple clinical studies. Due to the prescription of apixaban as antithrombotic therapy in patients with COVI
Externí odkaz:
https://doaj.org/article/e2d995fb422d4a5d9994c62c3a1621d0
Autor:
A. A. Rumyantsev, A. E. Protasova, M. Yu. Sheremet, A. Yu. Goryainova, M. V. Volkonskiy, A. G. Kedrova, S. V. Kuzmicheva, O. N. Aymamedova, Kh. S. Musaeva, S. M. Soroka, O. V. Romanchuk, V. N. Orlova, N. G. Graft, M. R. Ibragimova, Yu. I. Merzlikina, L. V. Stepura, L. B. Tatulova, A. A. Abasova, A. A. Akopyan, E. V. Arsenyeva, Yu. V. Vasilyeva, A. V. Belonogov, L. V. Krivolapova, A. A. Bobryshev, D. Yu. Vovk, I. A. Luev, N. R. Abidova, R. S. Zhikhorev, T. A. Zhelezkova, T. T. Grigoryan, T. A. Makarkina, V. A. Ekimov, A. V. Zhizhina, E. V. Karabina, O. A. Kuchevskaya, V. M. Filippova, T. A. Linchenko, A. A. Lisaeva, A. N. Fedorova, K. S. Maystrenko, E. V. Markizova, E. V. Kogay, E. P. Krasnorutskaya, M. E. Popova, Yu. Yu. Pchelin, R. A. Ryanzhina, D. B. Sidorov, E. B. Shakhnovich, S. M. Alekseev, M. V. Zinkevich, I. O. Belogortsev, V. A. Chubenko, V. M. Moiseenko, N. Kh. Abduloeva, A. A. Lebedinets, L. V. Strakh, L. K. Semenov, M. B. Bolieva, F. Z. Aydaeva
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 4, Pp 104-113 (2024)
Aim. To assess the efficacy and safety of lenvatinib and pembrolizumab for the treatment of mismatch repair-proficient endometrial cancer (EC) in routine clinical practice in Russia.Materials and methods. This multicenter, retrospective, cohort study
Externí odkaz:
https://doaj.org/article/b505b127d35446839d80501e03b80b14
Publikováno v:
Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, Vol 13, Iss 2, Pp 82-87 (2023)
Relevance. Surgical interventions used in cardiovascular surgery often lead to the development of many different etiology and manifestations of purulent-septic complications. The development of this pathology worsens the course of the postoperative p
Externí odkaz:
https://doaj.org/article/e21ea70f538949f38c85200b3fb3b6cc
Autor:
I. M. Bykov, D. A. Lubchenko, K. A. Popov, A. N. Stolyarova, M. A. Popova, O. V. Tsymbalov, E. E. Esaulenko
Publikováno v:
Кубанский научный медицинский вестник, Vol 30, Iss 2, Pp 25-34 (2023)
Background. In drug addiction treatment, the diagnostic process is based on the chemical toxicological determination of the intoxication substrate or its metabolite. Laboratory monitoring and prediction issues that could form the basis of secondary p
Externí odkaz:
https://doaj.org/article/f8d53324ef024ec6846102e5339b09e1